Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.2667 | 0.2966 |
Echinococcus granulosus | lamin dm0 | 0.003 | 0.4654 | 0.9947 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.2667 | 0.5681 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0029 | 0.4393 | 0.9433 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.2667 | 0.5651 |
Echinococcus multilocularis | lamin | 0.003 | 0.4654 | 0.9947 |
Echinococcus multilocularis | lamin dm0 | 0.003 | 0.4654 | 0.9947 |
Loa Loa (eye worm) | histone methyltransferase | 0.0009 | 0.0939 | 0.1926 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.1835 | 0.3873 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0004 | 0.0053 | 0.0199 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.4654 | 1 |
Brugia malayi | CXXC zinc finger family protein | 0.0029 | 0.4393 | 0.9433 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.2667 | 1 |
Trichomonas vaginalis | type II inositol 5-phosphatase, putative | 0.0004 | 0.0053 | 0.0199 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Loa Loa (eye worm) | intermediate filament protein | 0.003 | 0.4654 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.2667 | 0.5 |
Trichomonas vaginalis | sphingomyelinase C 2 precursor, putative | 0.0004 | 0.0053 | 0.0199 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.2667 | 1 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.4678 | 0.465 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0004 | 0.0053 | 0.0199 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1931 | 0.4082 |
Onchocerca volvulus | 0.003 | 0.4654 | 1 | |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0939 | 0.1916 |
Trichomonas vaginalis | carbon catabolite repressor protein, putative | 0.0004 | 0.0053 | 0.0199 |
Schistosoma mansoni | intermediate filament proteins | 0.003 | 0.4654 | 0.4625 |
Schistosoma mansoni | lamin | 0.003 | 0.4654 | 0.4625 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0055 | 0.8867 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.2667 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.2667 | 0.5681 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0009 | 0.092 | 0.1883 |
Onchocerca volvulus | 0.003 | 0.4654 | 1 | |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.2667 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.2667 | 0.5651 |
Trichomonas vaginalis | Phospholipase C precursor, putative | 0.0004 | 0.0053 | 0.0199 |
Echinococcus multilocularis | musashi | 0.003 | 0.4654 | 0.9947 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.4678 | 0.465 |
Trichomonas vaginalis | type IV inositol 5-phosphatase, putative | 0.0004 | 0.0053 | 0.0199 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0007 | 0.0634 | 0.1257 |
Trichomonas vaginalis | skeletal muscle/kidney enriched inositol 5-phosphatase, putative | 0.0004 | 0.0053 | 0.0199 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0015 | 0.1931 | 0.4061 |
Echinococcus granulosus | intermediate filament protein | 0.003 | 0.4654 | 0.9947 |
Onchocerca volvulus | 0.0029 | 0.4393 | 0.9433 | |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0634 | 0.1257 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.2667 | 0.2628 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.1835 | 0.3873 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.4558 | 0.9791 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.2667 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0004 | 0.0109 | 0.0056 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0016 | 0.2211 | 0.469 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.2667 | 1 |
Trichomonas vaginalis | ocrl type II inositol 5-phosphatase, putative | 0.0004 | 0.0053 | 0.0199 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.003 | 0.4654 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.2667 | 1 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0015 | 0.1931 | 0.4061 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0634 | 0.0584 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.2667 | 0.5 |
Trichomonas vaginalis | helicase, putative | 0.0007 | 0.0525 | 0.1969 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.2667 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.4393 | 0.4363 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.2667 | 1 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0634 | 0.1257 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.003 | 0.4654 | 1 |
Brugia malayi | intermediate filament protein | 0.003 | 0.4654 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Schistosoma mansoni | lamin | 0.003 | 0.4654 | 0.4625 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0016 | 0.2211 | 0.469 |
Echinococcus granulosus | cpg binding protein | 0.003 | 0.4678 | 1 |
Echinococcus multilocularis | cpg binding protein | 0.003 | 0.4678 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.2667 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0.0525 | 0.1969 |
Echinococcus granulosus | lamin | 0.003 | 0.4654 | 0.9947 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.2667 | 0.2628 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.2667 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0939 | 0.1916 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0007 | 0.0525 | 0.1969 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.2667 | 1 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0007 | 0.0634 | 0.1257 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.